Few people realize that prescription drugs have become a leading cause of death, disease, and disability. Adverse reactions to widely used drugs, such as psychotropics and birth control pills, as well as biologicals, result in FDA warnings against adverse reactions. The Risks of Prescription Drugs describes how most drugs approved by the FDA are under-tested for adverse drug reactions, yet offer few new benefits. Drugs cause more than 2.2 million hospitalizations and 110,000 hospital-based deaths a year. Serious drug ...
Read More
Few people realize that prescription drugs have become a leading cause of death, disease, and disability. Adverse reactions to widely used drugs, such as psychotropics and birth control pills, as well as biologicals, result in FDA warnings against adverse reactions. The Risks of Prescription Drugs describes how most drugs approved by the FDA are under-tested for adverse drug reactions, yet offer few new benefits. Drugs cause more than 2.2 million hospitalizations and 110,000 hospital-based deaths a year. Serious drug reactions at home or in nursing homes would significantly raise the total. Women, older people, and people with disabilities are least used in clinical trials and most affected. Health policy experts Donald Light, Howard Brody, Peter Conrad, Allan Horwitz, and Cheryl Stults describe how current regulations reward drug companies to expand clinical risks and create new diseases so millions of patients are exposed to unnecessary risks, especially women and the elderly. They reward developing marginally better drugs rather than discovering breakthrough, life-saving drugs. The Risks of Prescription Drugs tackles critical questions about the pharmaceutical industry and the privatization of risk. To what extent does the FDA protect the public from serious side effects and disasters? What is the effect of giving the private sector and markets a greater role and reducing public oversight? This volume considers whether current rules and incentives put patients' health at greater risk, the effect of the expansion of disease categories, the industry's justification of high U.S. prices, and the underlying shifts in the burden of risk borne by individuals in the world of pharmaceuticals. Chapters cover risks of statins for high cholesterol, SSRI drugs for depression and anxiety, and hormone replacement therapy for menopause. A final chapter outlines six changes to make drugs safer and more effective. Suitable for courses on health and aging, gender, disability, and minority studies, this book identifies the Risk Proliferation Syndrome that maximizes the number of people exposed to these risks. Additional Columbia / SSRC books on the privatization of risk and its implications for Americans: Bailouts: Public Money, Private ProfitEdited by Robert E. Wright Disaster and the Politics of InterventionEdited by Andrew Lakoff Health at Risk: America's Ailing Health System-and How to Heal ItEdited by Jacob S. Hacker Laid Off, Laid Low: Political and Economic Consequences of Employment InsecurityEdited by Katherine S. Newman Pensions, Social Security, and the Privatization of RiskEdited by Mitchell A. Orenstein
Read Less
Add this copy of The Risks of Prescription Drugs to cart. $12.00, very good condition, Sold by JDH Lawton OK rated 5.0 out of 5 stars, ships from LAWTON, OK, UNITED STATES, published 2010 by Columbia University Press.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Very good. Ex-library. 167 p. : ill.; 22 cm. LCCN 2010009014 Type of material Book Main title The risks of prescription drugs / edited by Donald W. Light. Published/Created New York: Columbia University Press, c2010. Description 167 p. : ill.; 22 cm. ISBN 9780231146920 (cloth: alk. paper) 0231146922 (cloth: alk. paper) 9780231146937 (pbk. : alk. paper) 0231146930 (pbk. : alk. paper) LC classification RA401. A3 R57 2010 Related names Light, Donald, 1942-Contents Bearing the risks of prescription drugs / Donald Light--The Food and Drug Administration: inadequate protection from serious risks / Donald Light--The commercialization of medical decisions: physicians and patients at risk / Howard Brody--Pharmaceuticals and the medicalization of social life / Allan Horwitz--Medicalization and risk scares: the case of menopause and HRT / Cheryl Stults and Peter Conrad--Toward safer prescribing and better drugs / Donald Light. LC Subjects United States. Food and Drug Administration. Pharmaceutical policy--United States. Pharmaceutical industry--Risk management. Drugs--Risk assessment. Other Subjects Drug Industry--standards--United States. Prescription Drugs--standards--United States. Drug Toxicity--United States. Medication Errors--prevention & control--United States. Risk Assessment--United States. Notes Includes bibliographical references. Series The Columbia University Press and Social Science Research Council series on the privatization of risk A Columbia/SSRC book Columbia University Press and Social Science Research Council series on the privatization of risk. Columbia/SSRC book. Dewey class no. 338.4/76151 Geographic area code n-us---NLM class no. 2010 M-013 QV 736 R5955 2010 National bib agency no. 101525532 Other system no. (OCoLC)ocn540015686
Add this copy of The Risks of Prescription Drugs to cart. $12.84, very good condition, Sold by ThriftBooks-Atlanta rated 5.0 out of 5 stars, ships from Austell, GA, UNITED STATES, published 2010 by Columbia University Press.
Add this copy of The Risks of Prescription Drugs to cart. $12.84, very good condition, Sold by ThriftBooks-Baltimore rated 4.0 out of 5 stars, ships from Halethorpe, MD, UNITED STATES, published 2010 by Columbia University Press.
Add this copy of The Risks of Prescription Drugs (a Columbia / Ssrc Book to cart. $12.85, very good condition, Sold by The Maryland Book Bank rated 5.0 out of 5 stars, ships from baltimore, MD, UNITED STATES, published 2010 by Columbia University Press.
Add this copy of The Risks of Prescription Drugs (a Columbia / Ssrc Book to cart. $13.42, fair condition, Sold by Jenson Books Inc rated 4.0 out of 5 stars, ships from Logan, UT, UNITED STATES, published 2010 by Columbia University Press.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
This item is fairly worn, but continues to work perfectly. Signs of wear can include aesthetic issues such as scratches, dents, worn corners, bends, tears, small stains, and partial water damage. All pages and the cover are intact, but the dust cover may be missing, if applicable. Pages may include excessive notes and highlighting, but the text is not obscured or unreadable. Satisfaction Guaranteed.
Add this copy of The Risks of Prescription Drugs to cart. $20.33, good condition, Sold by Anybook rated 5.0 out of 5 stars, ships from Lincoln, UNITED KINGDOM, published 2010 by Columbia University Press.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
This is an ex-library book and may have the usual library/used-book markings inside. This book has soft covers. In good all round condition. Please note the Image in this listing is a stock photo and may not match the covers of the actual item, 350grams, ISBN: 9780231146937.
Add this copy of The Risks of Prescription Drugs (a Columbia / Ssrc Book to cart. $39.32, good condition, Sold by Bonita rated 4.0 out of 5 stars, ships from Newport Coast, CA, UNITED STATES, published 2010 by Columbia University Press.
